Human Recombinant MIG (from E. coli)

Supplier: PeproTech

300-26-250UG 300-26-20UG 300-26-500UG 300-26-1MG 300-26-100UG 300-26-50UG 300-26-5UG
10773-726EA 1970.75 CAD
10773-726 10773-720 10773-728 10773-730 10773-724 10773-722 10773-718
Human Recombinant MIG (from E. coli)
Proteins and Peptides
MIG, a CXC chemokine, is produced by IFN-γ stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities, including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant Human MIG (CXCL9) is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines.

Ordering information: For research use only. Not for use in diagnostic or therapeutic procedures.
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR